Kaya Ltd.
Snapshot View

View in App

Prices View details >>

253.25 +6.80 ▲2.8%

31 March 2023, 04:01:00 PM
Volume: 793

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.kaya.in
Market Cap 330.85 Cr.
Enterprise Value(EV) 385.29 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -77.77 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-12
Industry PE 46.34 Trailing Twelve Months Ending 2022-12
Book Value / Share -48.02 Trailing Twelve Months Ending 2022-12
Price to Book Value -5.27 Calculated using Price: 253.25
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.31 Cr. 13,064,091 Shares
FaceValue 10
Company Profile
The company offers various skin care services and beauty treatments. Today, Kaya Clinics successfully offer best skin and hair care solutions that enhance the look and feel of your skin and hair beautifully. All of this takes place in our state-of-the-art and ambient clinics. Plus, the services that they offer are designed and supervised by a team of experts that include trained dermatologists and beauty therapists. Kaya's experts have also put forward in-depth research to develop products from 13 distinct skin care ranges. It is their concrete formulations that add to the efficiency of the products in order to meet customers’ customized beauty needs.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+2.76%
1 Week
-3.36%
1 Month
-3.45%
3 Month
-21.13%
6 Month
-29.88%
1 Year
-27.73%
2 Year
-14.53%
5 Year
-75.75%
10 Year

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 50.12 20.90 3.76 -11.41 -8.68 -7.57 -46.11 -55.98 -263.21
Return on Capital Employed (%) 22.58 16.56 5.43 -9.62 -5.06 -4.65 -7.24 -18.27 -53.94
Return on Assets (%) 9.99 8.99 2.24 -6.51 -4.87 -3.93 -14.21 -9.58 -18.64

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 83 235 251 229 210 158 82 54 -2 -34
Non Curr. Liab. 121 15 18 5 2 10 142 131 166 164
Curr. Liab. 125 129 142 190 137 180 189 182 196 247
Minority Int. 0 2 2 1 1 0 1 1
Equity & Liab. 329 378 412 425 351 349 413 368 361 378
Non Curr. Assets 105 143 181 239 231 234 318 290 255 259
Curr. Assets 224 235 231 187 120 115 95 78 106 119
Misc. Exp. not W/O
Total Assets 329 378 412 425 351 349 413 368 361 378

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 290 332 370 409 400 421 393 275 324 368
Other Income 81 15 12 11 10 4 9 15 12 5
Total Income 372 348 382 420 410 425 402 290 336 373
Total Expenditure -274 -296 -352 -425 -398 -406 -338 -248 -320 -389
PBIDT 97 52 30 -4 12 19 64 42 15 -16
Interest -4 -4 -4 -5 -7 -9 -22 -19 -21 -23
Depreciation -9 -12 -17 -20 -24 -29 -75 -60 -62 -62
Taxation -9 3 0 6 -21
Exceptional Items -37 -5
PAT 37 32 9 -27 -19 -14 -54 -37 -68 -101
Minority Interest 0 -1 -1 0 0 -1 -1 0
Share Associate -1 -1 -2
Other Related Items
Consolidated Net Profit 37 32 9 -29 -21 -16 -54 -38 -69 -102
Adjusted EPS 21 7 -22 -16 -12 -42 -29 -53 -78

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 34 92 29 5 -8 -12 22 47 32 30
Cash Fr. Inv. -132 -11 -17 -6 -42 24 -28 -12 4 -35
Cash Fr. Finan. 115 -73 0 0 33 -7 5 -47 -31 12
Net Change 18 7 13 -2 -16 6 -1 -12 5 7
Cash & Cash Eqvt 25 14 28 28 14 20 19 7 12 20

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 59.93 59.38 59.93 59.93 59.93 59.93 59.93 59.93 59.93
Public 40.07 40.62 40.07 40.07 40.07 40.07 40.07 40.07 40.07
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 13 Mar 2023
Announcement under Regulation 30 (LODR)-Acquisition
We would like to inform you that Kaya Middle East FZE (KME FZE) the step down subsidiary of Kaya Limited (the Company) has acquired a 100% equity stake in Kaya Beauty Clinic - Sole Proprietorship LLC (KBC LLC) a company operating clinics in Al Ain UAE. Pursuant to the recent changes in regulations which have liberalized foreign ownership foreign companies can now have 100% ownership in the UAE. Therefore KME FZE acquired KBC LLC. The details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with Circular No. CIR/CFO/CMD/4/2015 dated September 9 2015 are given in Annexure to this letter.
Thu, 23 Feb 2023
Announcement under Regulation 30 (LODR)-Acquisition
We would like to inform you that Kaya Middle East FZE (KME FZE) the step-down subsidiary of Kaya Limited (the Company) has acquired a 100% equity stake in Kaya Skin Care Clinic - Sole Proprietorship LLC (KSC LLC) a company operating clinics in Abu Dhabi UAE. Pursuant to the recent changes in regulations which have liberalized foreign ownership foreign companies can now have 100% ownership in the UAE.
Fri, 17 Feb 2023
Announcement under Regulation 30 (LODR)-Acquisition
We would like to inform you that Kaya Middle East FZE (KME FZE) the step down subsidiary of the Kaya Limited ( Company) has acquired a 100% equity stake in Kaya Trading Limited Liability Company (KTLLC). Pursuant to the recent changes in regulations which have liberalized foreign ownership foreign companies can now have 100% ownership in the UAE. Therefore KME FZE acquired KTLLC.

Technical Scans View Details >>

Fri, 31 Mar 2023
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Below Last Month Low Close Below Last Month Low
High Decrease in 3 Months High Decrease in 3 Months
High Decrease in 6 Months High Decrease in 6 Months
William %R Bullish William %R Bullish

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 235,878.62 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. 76,960.86 4,624.15 +1.3%
Divi's Laboratories Ltd. 75,014.78 2,826.00 +0.3%
Cipla Ltd. 72,696.02 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. 61,962.56 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. 52,030.91 1,543.40 +0.2%
Zydus Lifesciences Ltd. 49,749.83 491.00 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.00 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 21.13 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 31.30 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-12 27.55 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 81.03 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.86 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 24.11 491.00 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.26 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.50 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 6.03 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-12 3.20 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.04 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.19 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.88 491.00 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 0.04 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 491.00 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 491.00 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 491.00 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 491.00 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 491.00 +0.1%

FAQ's On Kaya Ltd.

What is Kaya share price?
Can I buy Kaya shares now?
What is the Market Cap of Kaya?
What is the 52 Week High and Low of Kaya?
What is the trend of Kaya share price?